Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

Case Reports in Pediatrics
doi 10.1155/2018/5412138
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients

Gout and Nucleic Acid Metabolism
2002English

Review of Long-Term Consequences of Maternal Methamphetamine Exposure

Physiological Research
MedicinePhysiology
2019English

Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Perinatal/Neonatal Case Presentation: Neonatal Acute Renal Failure Secondary to Maternal Exposure to Telmisartan, Angiotensin II Receptor Antagonist

Journal of Perinatology
GynecologyChild HealthPediatricsPerinatologyObstetrics
2003English

Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2002English

Patient With Drug-Induced Hepatic Injury Caused by Long-Term Administration of an Angiotesin II Receptor Antagonist, Losartan

Acta Hepatologica Japonica
Hepatology
2013English

"The Compromised Fetal and Neonatal Lives and Their Possible Long-Term Consequences"

Current Pediatric Reviews
Child HealthPediatricsPerinatology
2018English

Antagonist Effect of a Receptor-Mimicking Peptide Encoded by Human Angiotensin II Complementary RNA

Hypertension
Internal Medicine
1992English

In Vitro Pharmacological Properties of KRH-594, a Novel Angiotensin II Type 1 Receptor Antagonist.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy